GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Cash Flow for Lease Financing

Scinopharm Taiwan (TPE:1789) Cash Flow for Lease Financing : NT$-13 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan Cash Flow for Lease Financing?

Scinopharm Taiwan's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was NT$-3 Mil. Scinopharm Taiwan's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-13 Mil.

Compared with last quarter (NT$-3 Mil in Dec. 2024 ), Scinopharm Taiwan's Cash Flow for Lease Financing remained the same in Mar. 2025 (NT$-3 Mil).

Scinopharm Taiwan Cash Flow for Lease Financing Historical Data

The historical data trend for Scinopharm Taiwan's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan Cash Flow for Lease Financing Chart

Scinopharm Taiwan Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.77 -10.26 -11.19 -11.29 -12.47

Scinopharm Taiwan Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.11 -3.12 -3.13 -3.12 -3.47

Scinopharm Taiwan Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinopharm Taiwan Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Cash Flow for Lease Financing
Comparable Companies
ROCO:6620 ROCO:4114 TPE:3705 TPE:1720 ROCO:6576 ROCO:4105 ROCO:6785 TPE:4119 TPE:4746 TPE:1707 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Nan-Ke 8th Road, No. 1, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Website
https://www.scinopharm.com
Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. The company also conducts consulting and technical services. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines